Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis

被引：3
|
作者：
Singal, Amit G. [1 ,4 ]
Nagar, Saurabh P. [2 ]
Hitchens, Abby [2 ]
Davis, Keith L. [2 ]
Iyer, Shrividya [2 ,3 ]
机构：
[1] UT Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Digest Dis Ctr, Div Digest & Singal, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 03期
关键词：
SORAFENIB;
D O I：
10.1016/j.cgh.2021.11.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
  • [32] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [33] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Mara Persano
    Margherita Rimini
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    Lorenza Rimassa
    José Presa
    Gianluca Masi
    Changhoon Yoo
    Sara Lonardi
    Francesco Tovoli
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Tiziana Pressiani
    Takumi Kawaguchi
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Fabio Piscaglia
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Massimo Iavarone
    Giovanni Di Costanzo
    Fabio Marra
    Mario Scartozzi
    Emiliano Tamburini
    Giuseppe Cabibbo
    Francesco Giuseppe Foschi
    Marianna Silletta
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
  • [34] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
  • [35] Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Kuo, Yuan-Hung
    Lu, Sheng-Nan
    Chen, Yen-Yang
    Kee, Kwong-Ming
    Yen, Yi-Hao
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Wang, Jing-Houng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Hepatocellular carcinoma with nonalcoholic steatohepatitis
    Mori, S
    Yamasaki, T
    Sakaida, I
    Takami, T
    Sakaguchi, E
    Kimura, T
    Kurokawa, F
    Maeyama, S
    Okita, K
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 391 - 396
  • [37] Hepatocellular carcinoma with nonalcoholic steatohepatitis
    Sayaka Mori
    Takahiro Yamasaki
    Isao Sakaida
    Taro Takami
    Eiki Sakaguchi
    Teruaki Kimura
    Fumie Kurokawa
    Shiro Maeyama
    Kiwamu Okita
    Journal of Gastroenterology, 2004, 39 : 391 - 396
  • [38] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [39] Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
    de Castro, Tiago
    Welland, Sabrina
    Jochheim, Leonie
    Leyh, Cathrine
    Shmanko, Kateryna
    Finkelmeier, Fabian
    Jeliazkova, Petia
    Jefremow, Andre
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Roessler, Daniel
    Ben Khaled, Najib
    Enssle, Stefan
    Venerito, Marino
    Fruendt, Thorben W.
    Schultheiss, Michael
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Wirth, Thomas C.
    Marquardt, Jens U.
    Greil, Richard
    Fricke, Christina
    Guenther, Rainer
    Schmiderer, Andreas
    Bettinger, Dominik
    Wege, Henning
    Scheiner, Bernhard
    Mueller, Martina
    Strassburg, Christian P.
    Siebler, Juergen
    Ehmer, Ursula
    Waidmann, Oliver
    Weinmann, Arndt
    Pinter, Matthias
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [40] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Ishikawa, Toru
    Kunihiko, Tsuji
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi, Sr.
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    HEPATOLOGY, 2019, 70 : 217A - 218A
12345